Ongoing treatment was defined with the exposure definition used in the main analyses, including a grace period of 90 days, with patients being allowed to discontinue and reinitiate treatment multiple times
AGA technical review on intragastric balloons in the management of obesity
Option B : Increase GLP1 dose per protocol if tolerated and needed
Statistical analysis was performed by t -test (unpaired or paired, as indicated), one-way analysis of variance (ANOVA), two-way ANOVA (time treatment or genotype treatment) with post hoc comparisons (where appropriate, as indicated in the figure legends)
If the application is accepted and approved, the medication could become available as early as late 2027, although the timeline will ultimately depend on the FDA review process
It may aid in fat metabolism, helping the body process fats and carbohydrates more efficiently